Previous Article | Next Article 
Journal of Virology, January 1999, p. 290-296, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
RNase L Inhibitor Is Induced during Human Immunodeficiency
Virus Type 1 Infection and Down Regulates the 2-5A/RNase L Pathway
in Human T Cells
Camille
Martinand,
Céline
Montavon,
Tamim
Salehzada,
Michelle
Silhol,
Bernard
Lebleu, and
Catherine
Bisbal*
Institut de Génétique
Moléculaire de Montpellier (UMR 5535, CNRS-Université
de Montpellier II), 34293 Montpellier Cedex 5, France
Received 26 June 1998/Accepted 22 September 1998
The interferon-regulated 2-5A/RNase L pathway plays a major role in
the antiviral and antiproliferative activities of these cytokines.
Several viruses, however, have evolved strategies to escape the
antiviral activity of the 2-5A/RNase L pathway. In this context, we
have cloned a cDNA coding for the RNase L inhibitor (RLI), a protein
that specifically inhibits RNase L and whose regulated expression in
picornavirus-infected cells down regulates the activity of the
2-5A/RNase L pathway. We show here that RLI increases during the course
of human immunodeficiency virus type 1 (HIV-1) infection, which may be
related to the downregulation of RNase L activity that has been
described to occur in HIV-infected cells. In order to establish a
possible causal relationship between these observations, we have stably
transfected H9 cells with RLI sense or antisense cDNA-expressing
vectors. The overexpression of RLI causes a decrease in RNase L
activity and a twofold enhancement of HIV production. This increase in
HIV replication correlates with an increase in HIV RNA and proteins. In
contrast, reduction of RLI levels in RLI antisense cDNA-expressing
clones reverses the inhibition of RNase L activity associated with HIV
multiplication and leads to a threefold decrease in the viral load.
This anti-HIV activity correlated with a decrease in HIV RNA and
proteins. These findings demonstrate that the level of RLI, via its
modulation of RNase L activity, can severely impair HIV replication and
suggest the involvement of RLI in the inhibition of the 2-5A/RNase L
system observed during HIV infection.
*
Corresponding author. Mailing address: Institut
de Genetique Moleculaire de Montpellier, UMR 5535, CNRS-Université de Montpellier II, 1919, route de Mende,
34293 Montpellier Cedex 5, France. Phone: 33-4-67-61-36-58. Fax:
33-4-67-04-02-45. E-mail:
bisbal{at}jones.igm.cnrs-mop.fr.

Present address: Laboratoire Retrovirus, ORSTOM, 34032 Montpellier
Cedex 1,
France.
Journal of Virology, January 1999, p. 290-296, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Vendrame, D., Sourisseau, M., Perrin, V., Schwartz, O., Mammano, F.
(2009). Partial Inhibition of Human Immunodeficiency Virus Replication by Type I Interferons: Impact of Cell-to-Cell Viral Transfer. J. Virol.
83: 10527-10537
[Abstract]
[Full Text]
-
Randall, R. E., Goodbourn, S.
(2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol.
89: 1-47
[Abstract]
[Full Text]
-
Silverman, R. H.
(2007). Viral Encounters with 2',5'-Oligoadenylate Synthetase and RNase L during the Interferon Antiviral Response. J. Virol.
81: 12720-12729
[Full Text]
-
Andersen, D. S., Leevers, S. J.
(2007). The Essential Drosophila ATP-binding Cassette Domain Protein, Pixie, Binds the 40 S Ribosome in an ATP-dependent Manner and Is Required for Translation Initiation. J. Biol. Chem.
282: 14752-14760
[Abstract]
[Full Text]
-
Ye, Y., Hauns, K., Langland, J. O., Jacobs, B. L., Hogue, B. G.
(2007). Mouse Hepatitis Coronavirus A59 Nucleocapsid Protein Is a Type I Interferon Antagonist. J. Virol.
81: 2554-2563
[Abstract]
[Full Text]
-
Molinaro, R. J., Jha, B. K., Malathi, K., Varambally, S., Chinnaiyan, A. M., Silverman, R. H.
(2006). Selection and cloning of poly(rC)-binding protein 2 and Raf kinase inhibitor protein RNA activators of 2',5'-oligoadenylate synthetase from prostate cancer cells. Nucleic Acids Res
34: 6684-6695
[Abstract]
[Full Text]
-
Hosmalin, A., Lebon, P.
(2006). Type I interferon production in HIV-infected patients. J. Leukoc. Biol.
80: 984-993
[Abstract]
[Full Text]
-
Chen, Z.-q., Dong, J., Ishimura, A., Daar, I., Hinnebusch, A. G., Dean, M.
(2006). The Essential Vertebrate ABCE1 Protein Interacts with Eukaryotic Initiation Factors. J. Biol. Chem.
281: 7452-7457
[Abstract]
[Full Text]
-
Lingappa, J. R., Dooher, J. E., Newman, M. A., Kiser, P. K., Klein, K. C.
(2006). Basic Residues in the Nucleocapsid Domain of Gag Are Required for Interaction of HIV-1 Gag with ABCE1 (HP68), a Cellular Protein Important for HIV-1 Capsid Assembly. J. Biol. Chem.
281: 3773-3784
[Abstract]
[Full Text]
-
Sobol, P. T., Mossman, K. L.
(2006). ICP0 Prevents RNase L-Independent rRNA Cleavage in Herpes Simplex Virus Type 1-Infected Cells. J. Virol.
80: 218-225
[Abstract]
[Full Text]
-
Espert, L., Degols, G., Lin, Y.-L., Vincent, T., Benkirane, M., Mechti, N.
(2005). Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. J. Gen. Virol.
86: 2221-2229
[Abstract]
[Full Text]
-
Dooher, J. E., Lingappa, J. R.
(2004). Conservation of a Stepwise, Energy-Sensitive Pathway Involving HP68 for Assembly of Primate Lentivirus Capsids in Cells. J. Virol.
78: 1645-1656
[Abstract]
[Full Text]
-
Takedatsu, H., Shichijo, S., Katagiri, K., Sawamizu, H., Sata, M., Itoh, K.
(2004). Identification of Peptide Vaccine Candidates Sharing among HLA-A3+, -A11+, -A31+, and -A33+ Cancer Patients. Clin. Cancer Res.
10: 1112-1120
[Abstract]
[Full Text]
-
Rogez, C., Martin, M., Dereuddre-Bosquet, N., Martal, J., Dormont, D., Clayette, P.
(2003). Anti-Human Immunodeficiency Virus Activity of Tau Interferon in Human Macrophages: Involvement of Cellular Factors and {beta}-Chemokines. J. Virol.
77: 12914-12920
[Abstract]
[Full Text]
-
Smith, T. J., Silverman, R. H., Leib, D. A.
(2003). RNase L activity does not contribute to host RNA degradation induced by herpes simplex virus infection. J. Gen. Virol.
84: 925-928
[Abstract]
[Full Text]
-
Behera, A. K., Kumar, M., Lockey, R. F., Mohapatra, S. S.
(2002). 2'-5' Oligoadenylate Synthetase Plays a Critical Role in Interferon-gamma Inhibition of Respiratory Syncytial Virus Infection of Human Epithelial Cells. J. Biol. Chem.
277: 25601-25608
[Abstract]
[Full Text]
-
Le Roy, F., Bisbal, C., Silhol, M., Martinand, C., Lebleu, B., Salehzada, T.
(2001). The 2-5A/RNase L/RNase L Inhibitor (RNI) Pathway Regulates Mitochondrial mRNAs Stability in Interferon alpha -treated H9 Cells. J. Biol. Chem.
276: 48473-48482
[Abstract]
[Full Text]
-
Zheng, X., Silverman, R. H., Zhou, A., Goto, T., Kwon, B. S., Kaufman, H. E., Hill, J. M.
(2001). Increased Severity of HSV-1 Keratitis and Mortality in Mice Lacking the 2-5A-dependent RNase L Gene. IOVS
42: 120-126
[Abstract]
[Full Text]
-
Goodbourn, S., Didcock, L., Randall, R. E.
(2000). Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol.
81: 2341-2364
[Full Text]
-
Bisbal, C., Silhol, M., Laubenthal, H., Kaluza, T., Carnac, G., Milligan, L., Le Roy, F., Salehzada, T.
(2000). The 2'-5' Oligoadenylate/RNase L/RNase L Inhibitor Pathway Regulates Both MyoD mRNA Stability and Muscle Cell Differentiation. Mol. Cell. Biol.
20: 4959-4969
[Abstract]
[Full Text]